PharmaEngine, Inc.
4162
Rank in Stocks
#16020
PharmaEngine, Inc. is a biopharmaceutical firm specializing in the creation and... PharmaEngine, Inc. is a biopharmaceutical firm specializing in the creation and advancement of oncology therapeutics, primarily targeting markets in Taiwan and Europe. Its leading drug candidate is ONIVYDE, an innovative liposomal formulation of irinotecan. This topoisomerase 1 inhibitor is designed to treat metastatic pancreatic cancer. The company's pipeline also includes PEP06, currently in Phase I clinical trials for various cancers, and PEP07. PEP07, a Chk1 inhibitor in preclinical development, is being investigated for its ability to induce DNA damage and programmed cell death (apoptosis), leading to "replication catastrophe" in cancer cells. Established in 2002, PharmaEngine, Inc. maintains its corporate headquarters in Taipei, Taiwan.
Share Price
$1.53
Last synced: 2026-11-19
Market Cap
$219.80M
Change (1 day)
-4.06%
Change (1 year)
-31.18%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PharmaEngine, Inc. (4162)
Category
Healthcare
Dividend yield history for PharmaEngine, Inc. (4162)
PharmaEngine, Inc. (stock symbol: 4162) dividend yield (TTM) as of 2025: 8.52%
Average dividend yield, last 5 years : 3.54%
Average dividend yield, last 5 years : 3.54%
Dividend yield history for PharmaEngine, Inc. (4162) from 2008 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 3.67% | -56.92% |
| 2025 | 8.52% | 413.25% |
| 2024 | 1.66% | -12.17% |
| 2023 | 1.89% | -12.50% |
| 2022 | 2.16% | -37.75% |
| 2021 | 3.47% | 303.49% |
| 2020 | 0.86% | -41.10% |
| 2019 | 1.46% | -20.22% |
| 2018 | 1.83% | 66.36% |
| 2017 | 1.10% | 139.13% |
| 2016 | 0.46% | 9.52% |
| 2015 | 0.42% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.00% |
AU
|
|
| 0.49% |
BE
|
|
| 0.00% |
NL
|
Questions about PharmaEngine, Inc.'s dividend yield
What is PharmaEngine, Inc.'s dividend yield?
PharmaEngine, Inc.'s dividend yield is 3.67%, as of Nov 2026.
What was PharmaEngine, Inc.'s dividend yield in 2025?
In 2025, PharmaEngine, Inc.'s dividend yield was 8.52%, compared with 1.66% in 2024.
How has PharmaEngine, Inc.'s dividend yield changed since 2020?
From 2020 to 2025, PharmaEngine, Inc.'s dividend yield was highest in 2025 (8.52%) and lowest in 2020 (0.86%).
How does PharmaEngine, Inc.'s dividend yield compare with similar companies?
PharmaEngine, Inc.'s dividend yield (3.67%) is higher than that of all 5 similar companies listed above. The highest among them is CSL Limited, with 2.00%.